INTERVENTIONAL NEUROLOGY MARKET ANALYSIS

Interventional Neurology Market, by Product Type (Embolic Coils, Stents, Embolic Protection Devices, Flow Diverter Devices, Stent Retrievers, Revascularization Device, Guide Sheaths, Neck Reconstruction Device, Catheters, and Others), by Application (Cerebral Aneurysm, Subarachnoid Hemorrhage (SAH), Ischemic Strokes, Extracranial & Intracranial Atherosclerosis, Head and Neck Tumors, and Others), by Technique (Angioplasty, Coil Embolization, Embolectomy, Stenting, Thrombectomy, and Others), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022
Code : CMI56
Pages :156
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Interventional Neurology Market: Recent Market Developments

In June 2021, Terumo Europe, providing quality medical products and services, and MicroVention Europe, a neuroendovascular medical device company, welcomed the reimbursement of the RoadsaverTM carotid stent system, the next generation carotid stent, designed to prevent a plaque protrusion through the struts and provide a sustained embolic protection. This development follows the positive assessment from the French National Authority for Health (HAS), which highlighted a therapeutic benefit of the device

Moreover, in March 2022, India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc announced the launch of Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with Neurothrombectomy Devices (PRAAN) which will be used to create a post-market registry to assess clinical outcomes associated with the use of Medtronic market-released revascularization devices in patients experiencing acute ischemic stroke.